Pramipexole Related Compound A

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	AP106092095
CAS	106092-09-5
Structure
MDL Number	MFCD07368003
Molecular Weight	169.25
InChI Key	DRRYZHHKWSHHFT-BYPYZUCNSA-N

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease: Results of a Double-Blind, Placebo-Controlled, Parallel-Group Study

A Lieberman, A Ranhosky, D Korts

Neurology. 1997 Jul;49(1):162-8.

PMID: 9222185

Design, Synthesis, and Evaluation of Potent and Selective Ligands for the Dopamine 3 (D3) Receptor With a Novel in Vivo Behavioral Profile

Jianyong Chen, Gregory T Collins, Jian Zhang, Chao-Yie Yang, Beth Levant, James Woods, Shaomeng Wang

J Med Chem. 2008 Oct 9;51(19):5905-8.

PMID: 18785726

Differentiation of Dopamine Agonists and Their Role in the Treatment of Parkinson's Disease

D B Calne

J Neural Transm Suppl. 1999;56:185-92.

PMID: 10370912

Novel Multifunctional Dopamine D

Dan Luo, Horrick Sharma, Deepthi Yedlapudi, Tamara Antonio, Maarten E A Reith, Aloke K Dutta

Bioorg Med Chem. 2016 Nov 1;24(21):5088-5102.

PMID: 27591013

Pre-clinical Studies of Pramipexole: Clinical Relevance

J P Hubble

Eur J Neurol. 2000 May;7 Suppl 1:15-20.

PMID: 11054154

CAT	Size	Description	Price
AP106092095-1	50MG	Pharmaceutical Secondary Standard; Certified Reference Material	Inquiry
AP106092095-2	15MG	United States Pharmacopeia (USP) Reference Standard	Inquiry

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry